EV/EBITDA
-0.83
+0.01+1.19%
Fri, 07 Feb 2025 14:30:00 GMT
Summary
- As of February 8, 2025, OCX EV/EBITDA is -0.83, with a rise of +0.01 (+1.19%) during the most recent trading day.
- Over the past year, OCX EV/EBITDA has increased by +0.67 (+44.67%).
- OCX EV/EBITDA is now -101.86% below its all-time high of 44.67.
Performance
OCX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
OCX EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +1.2% | -1.9% | -1.9% |
1 m1 month | +8.8% | -9.3% | -9.5% |
3 m3 months | +28.4% | -29.1% | -29.5% |
6 m6 months | +40.3% | -0.1% | -33.0% |
ytdytd | +14.4% | -15.3% | -15.6% |
1 y1 year | +44.7% | +110.1% | -27.7% |
5 y5 years | +87.7% | -76.4% | -96.1% |
OCX EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -2.5% | -0.92 | +9.8% | |
3 m | 3-month | -0.81 | -2.5% | -1.20 | +30.8% |
6 m | 6-month | -0.81 | -2.5% | -1.52 | +45.4% |
1 y | 1-year | -0.68 | -22.1% | -1.74 | +52.3% |
3 y | 3-year | 44.67 | -101.9% | -95.35 | +99.1% |
5 y | 5-year | 44.67 | -101.9% | -95.35 | +99.1% |
alltime | all time | 44.67 | -101.9% | -95.35 | +99.1% |
OncoCyte EV/EBITDA History
Date | Value |
---|---|
2025 | -0.83(-14.4%) |
2024 | -0.97(-23.0%) |
2023 | -1.26(-47.5%) |
2022 | -2.40(-32.8%) |
2021 | -3.57(-37.0%) |
Date | Value |
---|---|
2020 | -5.67(+9.9%) |
2019 | -5.16(+49.6%) |
2018 | -3.45(-54.6%) |
2017 | -7.60(-57.6%) |
2016 | -17.94(+0.4%) |
2015 | -17.87 |
FAQ
- What is OncoCyte EV/EBITDA?
- What is the all time high EV/EBITDA for OncoCyte?
- What is OCX EV/EBITDA year-to-date change?
- What is OncoCyte EV/EBITDA year-on-year change?
What is OncoCyte EV/EBITDA?
The current EV/EBITDA of OCX is -0.83
What is the all time high EV/EBITDA for OncoCyte?
OncoCyte all-time high EV/EBITDA is 44.67
What is OCX EV/EBITDA year-to-date change?
OncoCyte EV/EBITDA has changed by +0.14 (+14.43%) since the beginning of the year
What is OncoCyte EV/EBITDA year-on-year change?
Over the past year, OCX EV/EBITDA has changed by +0.67 (+44.67%)